期刊文献+

海藻酸钠地塞米松凝胶圆窗给药后外淋巴液中地塞米松浓度的变化

Study the Pharmacokinetics of Dexamethasone in the Perilymph after the Sodium Alginate Dexamethasone Gel Transtympanic Administration in Vivo
在线阅读 下载PDF
导出
摘要 目的分析海藻酸钠地塞米松凝胶(Alg-Dex凝胶)经圆窗给药后地塞米松在外淋巴液中的浓度变化。方法健康豚鼠30只随机分成5组,每组6只,于每只豚鼠单侧(右耳)经圆窗给海藻酸钠地塞米松凝胶(45mg/ml)20μl后的1、2、3、4、5天分别用高压液相色谱仪分析外淋巴液中的地塞米松浓度。结果在Alg-Dex凝胶给药后1、2、3、4、5天在外淋巴液中均能检测到地塞米松,浓度分别为0.49±0.06、1.32±0.28、0.65±0.08、0.66±0.05、0.53±0.17mg/L,其中第2天浓度最高(1.32±0.28mg/L),第3~5天药物浓度较稳定,平均浓度为0.61±0.07mg/L。结论海藻酸钠能作为地塞米松良好的缓释载体,使其缓慢、持续地经圆窗膜渗透到外淋巴液中。 Objective To determine pharmacokinetics profiles of sodium alginate dexamethasone in perilymph after trans--round window administration of the sodium alginate dexamethasone gel in vivo. Methods 30 healthy guinea pig were randomly divided into 6 groups. Alg--Dex gel was placed into the niche of the round window of the guinea pig on the right ear. The perilymphetic samples were harvested on day 1,2,3,4 and 5 after administration of Alg-- Dex gel respectively. The concentrations of dexamethasone in perilymph were assayed with high performance liquid chromatograph (HPLC). Results Concentrations of dexamethasone in perilymph on day 1,2,3,4 and 5 after administration of Alg--Dex gel were 0. 49±0. 06,1. 32±0. 28,0.65±0. 08,0.66±0.05,0.53±0.17 mg/L respec- tively. Concentrations of dexamethasone in perilymph reached a peak on the second day and maintained 0.61± 0.07 mg/L steadily on following days after administration. Conclusion Dexamethasone can be released from the sodium alginate dexamethasone gel persisitently and steadily in vivo.
出处 《听力学及言语疾病杂志》 CAS CSCD 2008年第1期57-59,共3页 Journal of Audiology and Speech Pathology
基金 上海市科委基金资助项目(No:0341l9819)
关键词 海藻酸钠 地塞米松 圆窗 外淋巴液 高压液相色谱仪 Sodium alginate Dexamethasone Round window Perilymph HPLC
  • 相关文献

参考文献14

  • 1Stone JH,Francis HW.Immune-mediated inner ear disease[J].Current Curr Opin Rheumatol,2000,12:32.
  • 2Stover T,Yagi M,Raphael Y.Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer[J].Gene Ther,2000,7:377.
  • 3侯东明,吴皓,杨军,张萍,张顺国,陈洁.不同方式鼓室内给药后豚鼠耳蜗外淋巴液中地塞米松代谢动力学特征[J].临床耳鼻咽喉科杂志,2005,19(7):307-310. 被引量:17
  • 4Hahn H,Kammerer B,Di Mauro A,et al.Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration[J].Hear Res,2006,212:236.
  • 5樊华,张其清.海藻酸钠在药剂应用中的研究进展[J].中国药房,2006,17(6):465-467. 被引量:35
  • 6Zheng CH,Gao JQ,Zhang YP.A protein delivery system:biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres[J].Biochem Biophys Res Commun,2004,323:1 321.
  • 7刘娅,孙建军,孔维佳,江平,姜伟.离体圆窗膜对地塞米松不同制剂的通透性[J].中华耳鼻咽喉头颈外科杂志,2006,41(3):211-215. 被引量:5
  • 8Liu HJ,Dong MM,Chi FL.Dexamethasone pharmacokinetics in guinea pig inner ear perilymph[J].ORL J Otorhinolaryngol Relat Spec,2006,68:93.
  • 9Salt AN,Ma Y.Quantifi cation of solute entry into cochlear perilymph through the round window membrane[J].Hear Res,2001,154:88.
  • 10Chandrasekhar SS,Bubinstein RY,Kwartler JA,et al.Dexamethasone pharmacokinetics in the inner ears comparison of route of administration and use of facilitating agents[J].Otolaryngol Head Neck Surg,2000,122:521.

二级参考文献67

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部